The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network
Open accessAbstract
OBJECTIVE: White matter hyperintensities (WMHs) are areas of increased signal on T2-weighted magnetic resonance imaging (MRI) scans that most commonly reflect small vessel cerebrovascular disease. Increased WMH volume is associated with risk and progression of Alzheimer's disease (AD). These observations are typically interpreted as evidence that vascular abnormalities play an additive, independent role contributing to symptom presentation, but not core features of AD. We examined the severity and distribution of WMH in presymptomatic PSEN1, PSEN2, and APP mutation carriers to determine the extent to which WMH manifest in individuals genetically determined to develop AD. METHODS: The study comprised participants (n = 299; age = 39.03 ± 10.13) from the Dominantly Inherited Alzheimer Network, including 184 (61.5%) with a mutation that results in AD and 115 (38.5%) first-degree relatives who were noncarrier controls. We calculated the estimated years from expected symptom onset (EYO) by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were analyzed for total and regional WMH. Mixed-effects piece-wise linear regression was used to examine WMH differences between carriers and noncarriers with respect to EYO. RESULTS: Mutation carriers had greater total WMH volumes, which appeared to increase approximately 6 years before expected symptom onset. Effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years before estimated onset. INTERPRETATION: Autosomal-dominant AD is associated with increased WMH well before expected symptom onset. The findings suggest the possibility that WMHs are a core feature of AD, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease. Ann Neurol 2016;79:929-939.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“findings from previous studies have also shown that WMHs often occur prior to the presence of amyloid-β plaques in preclinical AD [19,20,21]”
From Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function (2023) · cites this paper as [19]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence suggests that white matter microstructural changes may be not only a marker of small vessel injury but also directly related to AD pathology. 53 , 54”
From White matter hyperintensity modulates the amyloid‐tau‐cognition association and anti‐amyloid treatment efficacy in asymptomatic older adults (2025) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“WMHs are considered an MRI detectable marker of white matter changes due to microvascular pathology, and are increased in autosomal-dominant Alzheimer’s disease (Lee et al., 2016).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Lee et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Regional Brain Changes in Aging Healthy Adults: General Trends, Individual Differences and Modifiers
Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A., Dahle, C., Gerstorf, D., & Acker, J. D. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi044 · Cited by 2,875
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1080/01621459.1970.10481147 · DOI
Cited by
Sorted by citations
Items 301–400 of 542
Shi, L., Buchanan, C. R., Cox, S. R., Hillary, R. F., Marioni, R. E., Campbell, A., Hayward, C., Stolicyn, A., Whalley, H. C., Harris, M. A., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12240 · Cited by 10
Leukoaraiosis and Gray Matter Volume Alteration in Older Adults: The PROOF Study
Celle, S., Boutet, C., Annweiler, C., Ceresetti, R., Pichot, V., Barthélemy, J., & Roche, F. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.747569 · Cited by 11
Garnier‐Crussard, A., Desestret, V., Cotton, F., Chételat, G., & Krolak‐Salmon, P. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.02.009 · Cited by 14
Atlason, H. E., Löve, Á., Róbertsson, V., Blitz, A. M., Sigurdsson, S. O., Gudnason, V. G., & Ellingsen, L. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274212 · Cited by 10
A novel causal mediation analysis approach for zero‐inflated mediators
Jiang, M., Lee, S., O’Malley, A. J., Stern, Y., & Li, Z. (2023) · Statistics in Medicine · doi:10.1002/sim.9689 · Cited by 12
Correlation between white matter hyperintensity and delusional symptoms in Alzheimer’s disease
Fan, W., Ma, S., Wang, Z., Han, Y., Liu, X., Gu, R., & Cai, Q. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05420-5 · Cited by 11
Morales, C. D., Cotton‐Samuel, D., Lao, P. J., Chang, J. F., Pyne, J. D., Alshikho, M. J., Lippert, R. V., Bista, K. C., Hale, C., Edwards, N. C., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01395-x · Cited by 10
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Iaccarino, L., Llibre‐Guerra, J. J., McDade, E., Edwards, L., Gordon, B. A., Benzinger, T. L. S., Hassenstab, J. J., Kramer, J. H., Li, Y., Miller, B. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae159 · Cited by 11
Soldan, A., Wang, J., Pettigrew, C. A., Davatzikos, C. A., Erus, G., Hohman, T. J., Dumitrescu, L. C., Bilgel, M., Resnick, S. M., Rivera‐Rivera, L. A., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae276 · Cited by 10
Silbert, L. C. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001508 · Cited by 11
Huang, H., Song, W., Wang, P., Zhu, Y., Zheng, L., Shen, C., Xu, H. M., & Qiu, J. (2025) · iRadiology · doi:10.1002/ird3.121 · Cited by 11
Pham, N. T. T., Graff‐Radford, J., Machulda, M. M., Spychalla, A. J., Schwarz, C. G., Senjem, M. L., Lowe, V. J., Vemuri, P., Kantarci, K., Knopman, D. S., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.008 · Cited by 10
Effects of white matter hyperintensity on cognitive function in PD patients: a meta-analysis
Zhao, W., Cheng, B., Zhu, T., Cui, Y., Shen, Y., Fu, X., Li, M., Feng, Y., & Zhang, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1203311 · Cited by 10
Mao, C., Li, J., Huang, X., Dong, L., Liu, C., Peng, B., Cui, L., & Gao, J. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2021.106552 · Cited by 10
Santos-Mandujano, R., Ryan, N. S., Chávez‐Gutiérrez, L., Sánchez‐Torres, C., & Meraz‐Ríos, M. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190978 · Cited by 11
Ramamurthy, E., Welch, G., Cheng, J., Yuan, Y., Gunsalus, L. M., Bennett, D. A., Tsai, L., & Pfenning, A. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.26.010330 · Cited by 10
Edwards, N. C., Lao, P. J., Alshikho, M. J., Ericsson, O. M., Rizvi, B. M., Petersen, M. E., O’Bryant, S. E., Aguilar, L. F., Simoes, S., Mapstone, M. E., et al. (2023) · medRxiv · doi:10.1101/2023.11.28.23298693 · Cited by 10
Edwards, L., Initiative, A. D. N., Thomas, K. R., Weigand, A. J., Edmonds, E. C., Clark, A. L., Walker, K. S., Brenner, E. K., Nation, D. A., Maillard, P., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221209 · Cited by 9
Xhima, K., Ottoy, J., Gibson, E., Zukotynski, K., Scott, C. J. M., Feliciano, G. J., Adamo, S. M., Kuo, P. H., BORRIE, M. J., Chertkow, H. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13791 · Cited by 9
Falla, D. S., Villegas‐Lanau, C. A., White, C. L., Serrano, G. E., Acosta‐Uribe, J., Mejía‐Cupajita, B., Villalba‐Moreno, N. D., Lu, P., Glatzel, M., Kofler, J., et al. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae122 · Cited by 16
15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN
Daniels, A. J., McDade, E., Llibre‐Guerra, J. J., Xiong, C., Perrin, R. J., Ibáñez, L., Supnet‐Bell, C., Cruchaga, C., Goate, A., Renton, A. E., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00047-7 · Cited by 11
Anwer, M., Poliakova, T., Albanus, R. D., Bhuiyan, M. I. H., Brickman, A. M., Chaudhuri, S., Cuddy, L. K., Eisenbaum, M., Foley, K. E., Gould, D. B., et al. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10210-x · Cited by 8
MacKenzie, J. L., Ivanova, N., Nell, H. J., Giordano, C. R., Terlecky, S. R., Agca, C., Ağca, Y., Walton, P. A., Whitehead, S. N., & Cechetto, D. F. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.01.026 · Cited by 9
Marco, N. D., di Palma, A., Frosini, A., & Initiative, A. D. N. (2023) · Annals of Mathematics and Artificial Intelligence · doi:10.1007/s10472-023-09885-8 · Cited by 9
Takase, H., Hamanaka, G., Hoshino, T., Ohtomo, R., Guo, S., Mandeville, E. T., Lo, E. H., & Arai, K. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231049 · Cited by 9
Gifford, K. A., Liu, D., Neal, J. E., Babicz, M. A., Thompson, J. L., Walljasper, L., Wiggins, M. E., Turchan, M., Pechman, K. R., Osborn, K. E., et al. (2018) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000494209 · Cited by 9
Kaufmann, H., & Palma, J. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13000 · Cited by 9
Pelcher, I., Puzo, C. J., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B. M., Palmisano, J. N., Vassey, E. A., Lindbergh, C. A., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200803 · Cited by 10
Chen, Z., Tan, Y. J., Lian, M. M., Tandiono, M., Foo, J. N., Lim, W. K., Kandiah, N., Tan, E., & Ng, A. S. L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.631407 · Cited by 9
Brown, S. S. G., Mak, E., Clare, I. C. H., Grigorova, M., Beresford‐Webb, J., Walpert, M., Jones, E., Hong, Y. T., Fryer, T. D., Coles, J., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.013 · Cited by 9
Yue, J., Zhang, Q., Xu, Y., Wang, P., Sun, X.-C., Yan, S., Li, A., Zhao, W.-W., Cao, D., Wang, Y., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1163809 · Cited by 10
Resende, E. D. P. F., Costa‐Silva, L., Carmona, K. C., Machado, T. H., Machado, J. C. B., Guimarães, H. C., Barbosa, M. T., Teixeira, A. L., de Souza, L. C., & Caramelli, P. (2016) · eNeurologicalSci · doi:10.1016/j.ensci.2016.11.011 · Cited by 10
Exploring the neuroprotective role of physical activity in cerebral small vessel disease
Anderson, M. E., Wind, E. J., & Robison, L. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148884 · Cited by 9
Chen, H., Dong, X., Wang, Y., Wang, K., Feng, G., Bai, T., Zhang, M., Gan, K., Peng, J.-J., Huang, W., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01548-z · Cited by 11
Yang, H. J., Lee, S., Koh, M. J., Lee, H. K., Kim, B. S., Kim, K. W., & Park, J. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210494 · Cited by 8
Aires, V., Ziegler‐Waldkirch, S., Friesen, M., Reichardt, W., Erny, D., Loreth, D., Harborne, A. C., Kretz, O., von Elverfeldt, D., & Meyer‐Luehmann, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.862918 · Cited by 8
Lao, P. J., Vorburger, R. S., Narkhede, A., Gazes, Y., Igwe, K. C., Colón, J. M., Amarante, E., Guzman, V. A., Last, B. S., Habeck, C. G., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00345 · Cited by 8
Chen, Z., Singh, P. K., Horn, K., Strickland, S., & Norris, E. H. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006612 · Cited by 8
Brain Imaging Abnormalities in Mixed Alzheimer’s and Subcortical Vascular Dementia
Lee, H., Wiggermann, V., Rauscher, A., Kames, C., Beg, M. F., Popuri, K., Tam, R. C., Lam, K., Jacova, C., Shahinfard, E., et al. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.65 · Cited by 8
Shaaban, C. E., Tudorascu, D., Glymour, M. M., Cohen, A. D., Thurston, R. C., Snyder, H. M., Hohman, T. J., Mukherjee, S., Yu, L., & Snitz, B. E. (2022) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2022.978350 · Cited by 9
Chen, T., Lee, W., Chen, J., Chang, S.-Y., Lin, C.-F., & Chen, H.-C. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01083-8 · Cited by 8
Rothstein, A., Zhang, Y., Briggs, A., Bernard, M. A., Shao, Y., Favilla, C. G., Sloane, K. L., Witsch, J., & Masurkar, A. V. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5948 · Cited by 8
Røvang, M. S., Selnes, P., MacIntosh, B. J., Groote, I. R., Pålhaugen, L., Sudre, C. H., Fladby, T., & Bjørnerud, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285683 · Cited by 8
Walking energetics and white matter hyperintensities in mid‐to‐late adulthood
Dougherty, R. J., Wanigatunga, A. A., An, Y., Tian, Q., Simonsick, E. M., Albert, M., Resnick, S. M., & Schrack, J. A. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12501 · Cited by 8
Fukui, Y., Hishikawa, N., Ichinose, J., Sato, K., Nakano, Y., Morihara, R., Ohta, Y., Yamashita, T., & Abe, K. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13007 · Cited by 7
Interaction of Vascular Damage and Alzheimer Dementia: Focal Damage and Disconnection
Haller, S., & Barkhof, F. (2017) · Radiology · doi:10.1148/radiol.2016161564 · Cited by 8
Roseborough, A. D., Jaremek, V., & Whitehead, S. N. (2021) · GeroScience · doi:10.1007/s11357-021-00435-w · Cited by 8
Ali, D. G., Abner, E. L., Bahrani, A. A., El Khouli, R., Gold, B. T., Jiang, Y., Wilcock, D. M., & Jicha, G. A. (2023) · Brain Sciences · doi:10.3390/brainsci13020218 · Cited by 6
Gong, Z., Laporte, J. P., Guo, A. Y., Bilgel, M., Bae, J., Fox, N. Y., de Rouen, A., Zhang, N., Taranath, A., de Cabo, R., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196638 · Cited by 7
“Additionally, clinical studies in genetic forms of AD, including autosomal dominant AD and Down’s syndrome, highlight impairments in WM integrity decades before the onset of symptoms (9, 24, 25).”
Self-citationThe Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease
Torre, M., Zanella, C. A., & Feany, M. Β. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.12.013 · Cited by 8
Shang, H., Liu, T., Gong, W., & Zhao, Y. X. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108259 · Cited by 6
White matter hyperintensity severity modifies gut metabolite association with cognitive outcomes
Kijpaisalratana, N., Phuah, C., Ament, Z., Bhave, V. M., Guarniz, A. G., Duskin, J. A., Couch, C. A., Irvin, M. R., & Kimberly, W. T. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100086 · Cited by 7
Xu, M., Yi, X., Huang, S., Wang, Q.-H., Lai, Y., Wang, Z., Fan, D., Zeng, G., Bai, Y., Shen, Y., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03369-5 · Cited by 8
Leone, R., Kobeleva, X., Rowe, B., Choupan, J., Ringman, J. M., & Barisano, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70588 · Cited by 8
Parent, O., Alasmar, Z., Osborne, S., Bussy, A., Costantino, M., Fouquet, J. P., Quesada, D., Pastor‐Bernier, A., Fajardo-Valdez, A., Binette, A. P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70832-2 · Cited by 13
Hayden, E. Y., Huang, J., Charreton, M., Nuñez, S., Putman, J. N., Teter, B., Lee, J. T., Welch, A. E., Frautschy, S. A., Cole, G. M., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00786-0 · Cited by 7
Fernández, A., Ramírez‐Toraño, F., Bruña, R., Zuluaga, P., Esteba‐Castillo, S., Abásolo, D., Moldenhauer, F., Shumbayawonda, E., Maestú, F., & García‐Alba, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.988540 · Cited by 7
Schoemaker, D., Velilla-Jiménez, L. M., Zuluaga, Y., Baena, A. Y., Ospina, C., Bocanegra, Y., Álvarez, S., Ochoa‐Escudero, M., Guzmán‐Vélez, E., Martinez, J. E., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210313 · Cited by 7
Thomas, K. R., Weigand, A. J., Cota, I. H., Edmonds, E. C., Wierenga, C. E., Bondi, M. W., Bangen, K. J., & Initiative, A. D. N. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00495-8 · Cited by 8
Brain frailty and small vessel disease for stroke outcome prediction
Yassi, N., Flicker, L. A., & Campbell, B. C. V. (2019) · Neurology · doi:10.1212/wnl.0000000000008880 · Cited by 7
Neuroimaging within the Dominantly Inherited Alzheimer’s Network (DIAN): PET and MRIPreprint
McKay, N. S., Gordon, B. A., Hornbeck, R. C., Jack, C. R., Koeppe, R. A., Flores, S. E., Keefe, S., Hobbs, D. A., Joseph‐Mathurin, N., Wang, Q., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.25.485799 · Cited by 9
Falla, D. S., Villegas‐Lanau, C. A., White, C. L., Serrano, G. E., Acosta‐Uribe, J., Mejía‐Cupajita, B., Villalba‐Moreno, N. D., Lu, P., Glatzel, M., Kofler, J., et al. (2023) · medRxiv · doi:10.1101/2023.08.14.23294081 · Cited by 7
Gómez, G., Shi, L., Fohner, A. E., Chen, J., Yang, Y., Fornage, M., Duggan, M. R., Peng, Z., Daya, G. N., Tin, A., et al. (2024) · medRxiv · doi:10.1101/2024.10.07.24314972 · Cited by 6
Miner, A. E., Groh, J. R., Farris, C. W., Hattiangadi, S., Cui, A., Brickman, A. M., Alshikho, M. J., Rabinovici, G. D., Rosen, H. J., Cobigo, Y., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70085 · Cited by 5
Levit, A., Gibson, A., Hough, O., Jung, Y., Ağca, Y., Agca, C., Hachinski, V., Allman, B. L., & Whitehead, S. N. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02476-w · Cited by 6
Wu, L., Jin, L., Li, L., Yu, K., Wu, J., Lei, Y., Jiang, S., & He, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1268566 · Cited by 7
Hybrid PET/MRI in Neurodegenerative Disorders
Keir, G., Li, Y., & Chiang, G. C.-Y. (2024) · Advances in Clinical Radiology · doi:10.1016/j.yacr.2024.04.013 · Cited by 6
Parental History of Dementia Is Associated with Increased Small Vessel Cerebrovascular Disease
Stamm, B. C., Lao, P. J., Rizvi, B. M., Colón, J. M., Igwe, K. C., Chesebro, A. G., Maas, B., Schupf, N., Mayeux, R. P., Manly, J. J., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz291 · Cited by 6
Shi, Y., Zhao, Z., Tang, H., & Huang, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.866312 · Cited by 7
Brenner, E. K., Initiative, A. D. N., Weigand, A. J., Edwards, L., Thomas, K. R., Edmonds, E. C., Bondi, M. W., & Bangen, K. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221178 · Cited by 6
Ali, D. G., Bahrani, A. A., Khouli, R. H. E., Gold, B. T., Jiang, Y., Zachariou, V., Wilcock, D. M., & Jicha, G. A. (2023) · Brain and Behavior · doi:10.1002/brb3.3209 · Cited by 5
Differences in Alzheimer’s Disease–Related Pathology Profiles Across Apolipoprotein Groups
Morrison, C., Dadar, M., Kamal, F., Collins, D. L., & Initiative, A. D. N. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad254 · Cited by 6
Schindler, L. S., Subramaniapillai, S., Ambikairajah, A., Barth, C., Crestol, A., Voldsbekk, I., Beck, D., Gurholt, T. P., Topiwala, A., Suri, S., et al. (2023) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2023.1320640 · Cited by 6
Gu, X., Chu, T., Liu, L., & Han, X. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.12.016 · Cited by 6
Implication of Small Vessel Disease MRI Markers in Alzheimer’s Disease and Lewy Body Disease1
Park, M.-C., Baik, K., Lee, Y., Kang, S. W., Jung, J. H., Jeong, S. H., Lee, P. H., Sohn, Y. H., & Ye, B. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210669 · Cited by 6
Ahmad, S., Wu, T., Arnold, M., Hankemeier, T., Ghanbari, M., Roshchupkin, G. V., Uitterlinden, A. G., Neitzel, J., Kraaij, R., van Duijn, C. M., et al. (2024) · medRxiv · doi:10.1101/2024.12.16.24317793 · Cited by 6
Brown, T. M., James, S., Nicholas, J. M., Keuss, S. E., Keshavan, A., Malone, I. B., Coath, W., Murray‐Smith, H., Cash, D. M., Barkhof, F., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213975 · Cited by 5
Lao, P. J., Edwards, N., Aguilar, L. F., Alshikho, M. J., Smith, A. P., LeMay, R., Hahm, J., Rizvi, B. M., Tudorascu, D., Rosas, H. D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70679 · Cited by 5
Nasiri, H., Khosravi, F., Saberian, P., Kavian, M., Mozafar, M., Torabi, P., Malekzadeh, T., Hadavi, S. M., Rezaee, A., Ghorbanalinejad, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25694-x · Cited by 6
Cortical Thickness and Hippocampal Volume in Vascular and Non-vascular Depressed Patients
Egglefield, D. A., Schiff, S., Motter, J. N., Grinberg, A., Rutherford, B. R., & Sneed, J. R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.697489 · Cited by 5
Role of white matter hyperintensity in effects of apolipoprotein E on cognitive injury
Raber, J., & Silbert, L. C. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1176690 · Cited by 5
Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer’s disease
Yoshida, K., Kato, D., Sugio, S., Takeda, I., & Wake, H. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1154196 · Cited by 6
Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer’s Disease
Law, L. L., Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., Dowling, N. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160642 · Cited by 6
What can the topology of white matter structural networks tell us about mild cognitive impairment?
Berlot, R., & O'Sullivan, M. J. (2017) · Future Neurology · doi:10.2217/fnl-2016-0022 · Cited by 5
Piriz, A. L., Reyes, D., Narkhede, A., Guzman, V. A., Viqar, F., Meier, I. B., Budge, M., Mena, P. R., Dashnaw, S. M., Lee, J. H., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180807 · Cited by 5
Chondroitin Sulphate Proteoglycan Axonal Coats in the Human Mediodorsal Thalamic Nucleus
Pantazopoulos, H., Hossain, N. M., Chelini, G., Durning, P. T., Barbas, H., Zikopoulos, B., & Berretta, S. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.934764 · Cited by 5
Garnier‐Crussard, A., & Chételat, G. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13372 · Cited by 5
Unschuld, P. G. (2018) · Neurodegenerative Diseases · doi:10.1159/000486565 · Cited by 5
Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure
Gifford, K. A., Liu, D., Neal, J. E., Acosta, L. M. Y., Bell, S. P., Wiggins, M. E., Wisniewski, K. M., Godfrey, M., Logan, L. A., Hohman, T. J., et al. (2018) · Assessment · doi:10.1177/1073191118773870 · Cited by 5
Mito, R., Dhollander, T., Xia, Y., Raffelt, D. A., Salvado, O., Churilov, L. P., Rowe, C. C., Brodtmann, A. G., Villemagne, V. L., & Connelly, A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/623124 · Cited by 5
Wang, S., Li, T., Zhao, B., Dai, W., Yao, Y., Li, C., Li, T., Hongtu Zhu, B., & Zhang, H. (2023) · Genome Research · doi:10.1101/gr.277905.123 · Cited by 5
Du, L., Langhough, R. E., Hermann, B. P., Jonaitis, E. M., Betthauser, T. J., Rivera‐Rivera, L. A., Cody, K. A., Chin, N. A., Cadman, R. V., Johnson, K. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70831 · Cited by 4
The blood metabolome of brain health in midlife and influences of genes, microbiome and exposome
Ahmad, S., Wu, T., Arnold, M., Hankemeier, T., Ghanbari, M., Roshchupkin, G. V., Uitterlinden, A. G., Borkowski, K., Neitzel, J., Kraaij, R., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01149-4 · Cited by 10
What Can We Learn About Alzheimer’s Disease from People with Down Syndrome?
Maure‐Blesa, L., Rodríguez‐Baz, Í., Carmona‐Iragui, M., & Fortea, J. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_546 · Cited by 5
Guo, A. Y., Laporte, J. P., Singh, K., Bae, J., Bergeron, K., de Rouen, A., Fox, N., Zhang, N., Carino, I., Faulkner, M. E., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70182 · Cited by 5
Gu, X., Zhao, M., Han, X., & Liu, L. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.105679 · Cited by 5
Incremental Value of Multidomain Risk Factors for Dementia Prediction: A Machine Learning Approach
Tan, W. Y., Hargreaves, C. A., Dawe, G. S., Hsu, W., Lee, M. L., Vipin, A., Kandiah, N., & Hilal, S. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.07.016 · Cited by 4
Chen, Y., Wang, Y., Zhang, M., Zhou, Y., Zhang, H., Li, P., & Wu, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1436030 · Cited by 4
Barthelson, K., Protzman, R. A., Snel, M. F., Hemsley, K. M., & Lardelli, M. T. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167651 · Cited by 6
Metadata
- Authors
- Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., Cairns, N. J., Holtzman, D. M., Buckles, V., Ghetti, B., McDade, E., Martins, R. N., Saykin, A. J., Masters, C. L., Ringman, J. M., Ryan, N. S., Förster, S., Laske, C., Schofield, P. R., Sperling, R. A., Salloway, S., Correia, S., Jack, C., Weiner, M., Bateman, R. J., Morris, J. C., Mayeux, R., Brickman, A. M., & for the Dominantly Inherited Alzheimer Network
- Affiliations
- New York State Psychiatric Institute (US)
- Fordham University (US)
- Albert Einstein College of Medicine (US)
- Columbia University Irving Medical Center (US)
- NewYork–Presbyterian Hospital (US)
- Washington University in St. Louis (US)
- Icahn School of Medicine at Mount Sinai (US)
- UCL Queen Square Institute of Neurology (GB)
- Indiana University Indianapolis (US)
- Edith Cowan University (AU)
- The University of Melbourne (AU)
- University of Southern California (US)
- German Center for Neurodegenerative Diseases (DE)
- UNSW Sydney (AU)
- Brigham and Women's Hospital (US)
- Brown University (US)
- Mayo Clinic (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Brickman, Adam M.
- ORCID
- Lee, Seonjoo
- Zimmerman, Molly E.
- Tosto, Giuseppe
- Benzinger, Tammie L.S.
- Marcus, Daniel S.
- Fagan, Anne M.
- Goate, Alison
- Fox, Nick C.
- Holtzman, David M.
- Ghetti, Bernardino
- McDade, Eric
- Martins, Ralph N.
- Saykin, Andrew J.
- Masters, Colin L.
- Ringman, John M.
- Ryan, Natalie S.
- Förster, Stefan
- Laske, Christoph
- Schofield, Peter R.
- Sperling, Reisa A.
- Salloway, Stephen
- Correia, Stephen
- Jack, Clifford
- Weiner, Michael
- Bateman, Randall J.
- Morris, John C.
- Mayeux, Richard
- Brickman, Adam M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2016-04-27
- Volume
- 79
- Issue
- 6
- Pages
- 929-939
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC4884146
- OpenAlex
- W2309640507
- Cited by
- 542
- References
- 51
- Citations by year
- 2026: 49 · 2025: 58 · 2024: 53 · 2023: 68 · 2022: 65 · 2021: 65 · 2020: 66 · 2019: 46 · 2018: 38 · 2017: 25 · 2016: 8
- FWCI
- 34.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- Australasian Journal of Paramedicine (submittedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- PMC
- Funders
- NIH/NIA (U19 AG032438, AG051348)
- NIHR Queen Square Dementia BRU
- German Center for Neurodegenerative Diseases (DZNE)
- Brain Exit Foundation Fellowship
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- white matter hyperintensities, Alzheimer's disease, autosomal dominant Alzheimer's disease, presymptomatic carriers, presenilin 1, presenilin 2, APP, cerebral small vessel disease, genetic risk
- MeSH terms
- Adult, Alzheimer Disease, Female, Heterozygote, Humans, Magnetic Resonance Imaging, Male, Peptide Fragments, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Genetic Predisposition to Disease, Presenilin-1, Presenilin-2, Young Adult, Neuroimaging, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
